DE3786309T2 - Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme. - Google Patents
Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme.Info
- Publication number
- DE3786309T2 DE3786309T2 DE87112279T DE3786309T DE3786309T2 DE 3786309 T2 DE3786309 T2 DE 3786309T2 DE 87112279 T DE87112279 T DE 87112279T DE 3786309 T DE3786309 T DE 3786309T DE 3786309 T2 DE3786309 T2 DE 3786309T2
- Authority
- DE
- Germany
- Prior art keywords
- gly
- peo
- polymer
- tmc
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012377 drug delivery Methods 0.000 title claims description 6
- 125000002947 alkylene group Chemical group 0.000 title description 2
- 229920000728 polyester Polymers 0.000 title 1
- 229920000642 polymer Polymers 0.000 claims description 42
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 41
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 39
- 108010006025 bovine growth hormone Proteins 0.000 claims description 22
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 16
- -1 poly(ethylene oxide) Polymers 0.000 claims description 14
- 239000011149 active material Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 229920005604 random copolymer Polymers 0.000 claims description 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 35
- 239000002202 Polyethylene glycol Substances 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 23
- 229920001223 polyethylene glycol Polymers 0.000 description 23
- 229910001868 water Inorganic materials 0.000 description 23
- 239000000243 solution Substances 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000835 fiber Substances 0.000 description 15
- 239000010408 film Substances 0.000 description 15
- 239000000017 hydrogel Substances 0.000 description 15
- 239000000463 material Substances 0.000 description 11
- 229920000428 triblock copolymer Polymers 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229920001400 block copolymer Polymers 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229920001993 poloxamer 188 Polymers 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 3
- 229920002065 Pluronic® P 105 Polymers 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001146 hypoxic effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 239000004416 thermosoftening plastic Substances 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 208000021017 Weight Gain Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000001226 reprecipitation Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/64—Polyesters containing both carboxylic ester groups and carbonate groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Polyesters Or Polycarbonates (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/903,797 US4716203A (en) | 1986-09-05 | 1986-09-05 | Diblock and triblock copolymers |
| US06/903,801 US4882168A (en) | 1986-09-05 | 1986-09-05 | Polyesters containing alkylene oxide blocks as drug delivery systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3786309D1 DE3786309D1 (de) | 1993-07-29 |
| DE3786309T2 true DE3786309T2 (de) | 1994-02-10 |
Family
ID=27129378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE87112279T Expired - Fee Related DE3786309T2 (de) | 1986-09-05 | 1987-08-25 | Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0258780B1 (enExample) |
| KR (1) | KR880003985A (enExample) |
| AU (1) | AU605172B2 (enExample) |
| BR (1) | BR8704648A (enExample) |
| CA (1) | CA1283988C (enExample) |
| DE (1) | DE3786309T2 (enExample) |
| DK (1) | DK462287A (enExample) |
| ES (1) | ES2058081T3 (enExample) |
| FI (1) | FI873840A7 (enExample) |
| GR (1) | GR3008526T3 (enExample) |
| HU (1) | HU205711B (enExample) |
| IL (1) | IL83764A (enExample) |
| NZ (1) | NZ221647A (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9401703A (nl) * | 1994-10-14 | 1996-05-01 | Rijksuniversiteit | Kauwgom. |
| US5702717A (en) * | 1995-10-25 | 1997-12-30 | Macromed, Inc. | Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers |
| US5665428A (en) * | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
| DE19726412A1 (de) * | 1997-06-21 | 1998-12-24 | Merck Patent Gmbh | Implantatmaterial mit einer Träger-Wirkstoff-Kombination |
| US6201072B1 (en) | 1997-10-03 | 2001-03-13 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| US6117949A (en) * | 1998-10-01 | 2000-09-12 | Macromed, Inc. | Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| KR20010030891A (ko) * | 1997-10-03 | 2001-04-16 | 마크로메드 인코퍼레이션 | 가역적 열 겔화 성질을 갖는 생분해성 저분자량 트리블럭폴리(락티드-코-글리콜리드) 폴리에틸렌 글리콜 공중합체 |
| US6004573A (en) * | 1997-10-03 | 1999-12-21 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| US7662409B2 (en) | 1998-09-25 | 2010-02-16 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
| US7018645B1 (en) | 2000-04-27 | 2006-03-28 | Macromed, Inc. | Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties |
| AU2002249101B2 (en) | 2001-03-23 | 2005-10-20 | Gumlink A/S | Coated degradable chewing gum with improved shelf life and process for preparing same |
| WO2002076228A1 (en) * | 2001-03-23 | 2002-10-03 | Gumlink A/S | Degradable resin substitute for chewing gum |
| EP1408876A4 (en) | 2001-06-22 | 2004-09-22 | Durect Corp | ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE |
| EP1476489B8 (en) | 2002-02-15 | 2008-10-08 | Nektar Therapeutics Al, Corporation | Hydrolytically degradable alkylene oxide based polymers |
| CA2483778A1 (en) | 2002-04-29 | 2003-11-13 | Gel-Del Technologies, Inc. | Biomatrix structural containment and fixation systems and methods of use thereof |
| EP1504047B1 (en) * | 2002-05-03 | 2007-12-12 | Janssen Pharmaceutica N.V. | Polymeric microemulsions |
| US7649023B2 (en) | 2002-06-11 | 2010-01-19 | Novartis Ag | Biodegradable block copolymeric compositions for drug delivery |
| BRPI0314042B8 (pt) | 2002-09-06 | 2021-05-25 | Calando Pharmaceuticals Inc | polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência |
| WO2004028268A1 (en) | 2002-09-24 | 2004-04-08 | Gumlink A/S | Chewing gum comprising at least two different biodegradable polymers |
| ATE404072T1 (de) | 2002-09-24 | 2008-08-15 | Gumlink As | Biologisch abbaubarer kaugummi enthaltend wenigstens ein biologish abbaubares polymer mit hochmolekularem gewicht |
| DE60323055D1 (de) | 2003-05-06 | 2008-10-02 | Gumlinck As | Methode zur Herstellung von Kaugummigranulat und komprimierten Kaugummiprodukten, sowie ein Kaugummigranuliersystem |
| EP1474995B1 (en) | 2003-05-06 | 2012-11-14 | Gumlink A/S | A method for producing chewing gum granules, a gum composition extruder and granulating system, and a chewing gum product |
| US8465537B2 (en) | 2003-06-17 | 2013-06-18 | Gel-Del Technologies, Inc. | Encapsulated or coated stent systems |
| EP1660013A4 (en) | 2003-08-26 | 2011-07-20 | Gel Del Technologies Inc | BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM |
| US8529939B2 (en) | 2003-12-08 | 2013-09-10 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
| US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
| WO2009086483A2 (en) | 2007-12-26 | 2009-07-09 | Gel-Del Technologies, Inc. | Biocompatible protein particles, particle devices and methods thereof |
| WO2010057177A2 (en) | 2008-11-17 | 2010-05-20 | Gel-Del Technologies, Inc. | Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof |
| US20110160159A1 (en) | 2009-09-15 | 2011-06-30 | John Ryan | Treatment of cancer |
| WO2011146638A1 (en) | 2010-05-18 | 2011-11-24 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
| US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| EP4192509A1 (en) | 2020-08-05 | 2023-06-14 | Ellipses Pharma Ltd | Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3736646A (en) * | 1971-10-18 | 1973-06-05 | American Cyanamid Co | Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures |
| US4047533A (en) * | 1976-09-20 | 1977-09-13 | American Cyanamid Company | Absorbable surgical sutures coated with polyoxyethylene-polyoxypropylene copolymer lubricant |
| US4429080A (en) * | 1982-07-01 | 1984-01-31 | American Cyanamid Company | Synthetic copolymer surgical articles and method of manufacturing the same |
| US4438253A (en) * | 1982-11-12 | 1984-03-20 | American Cyanamid Company | Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same |
| US4452973A (en) * | 1982-11-12 | 1984-06-05 | American Cyanamid Company | Poly(glycolic acid)/poly(oxyethylene) triblock copolymers and method of manufacturing the same |
-
1987
- 1987-08-25 DE DE87112279T patent/DE3786309T2/de not_active Expired - Fee Related
- 1987-08-25 EP EP87112279A patent/EP0258780B1/en not_active Expired - Lifetime
- 1987-08-25 ES ES87112279T patent/ES2058081T3/es not_active Expired - Lifetime
- 1987-09-02 NZ NZ221647A patent/NZ221647A/xx unknown
- 1987-09-03 CA CA000546072A patent/CA1283988C/en not_active Expired - Fee Related
- 1987-09-03 IL IL83764A patent/IL83764A/xx not_active IP Right Cessation
- 1987-09-04 AU AU77970/87A patent/AU605172B2/en not_active Ceased
- 1987-09-04 DK DK462287A patent/DK462287A/da not_active Application Discontinuation
- 1987-09-04 FI FI873840A patent/FI873840A7/fi not_active Application Discontinuation
- 1987-09-04 KR KR870009842A patent/KR880003985A/ko not_active Ceased
- 1987-09-04 BR BR8704648A patent/BR8704648A/pt not_active Application Discontinuation
- 1987-09-04 HU HU873970A patent/HU205711B/hu not_active IP Right Cessation
-
1993
- 1993-07-16 GR GR920403165T patent/GR3008526T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0258780A3 (en) | 1988-05-18 |
| IL83764A (en) | 1991-05-12 |
| FI873840L (fi) | 1988-03-06 |
| AU605172B2 (en) | 1991-01-10 |
| HU205711B (en) | 1992-06-29 |
| DK462287A (da) | 1988-03-06 |
| EP0258780A2 (en) | 1988-03-09 |
| KR880003985A (ko) | 1988-05-31 |
| DK462287D0 (da) | 1987-09-04 |
| EP0258780B1 (en) | 1993-06-23 |
| FI873840A7 (fi) | 1988-03-06 |
| CA1283988C (en) | 1991-05-07 |
| IL83764A0 (en) | 1988-02-29 |
| NZ221647A (en) | 1990-09-26 |
| ES2058081T3 (es) | 1994-11-01 |
| BR8704648A (pt) | 1988-04-26 |
| DE3786309D1 (de) | 1993-07-29 |
| FI873840A0 (fi) | 1987-09-04 |
| GR3008526T3 (enExample) | 1993-10-29 |
| HUT52945A (en) | 1990-09-28 |
| AU7797087A (en) | 1988-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3786309T2 (de) | Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme. | |
| US4882168A (en) | Polyesters containing alkylene oxide blocks as drug delivery systems | |
| DE69006216T2 (de) | Biodegradierbares system zur regeneration des perodontiums. | |
| DE69636626T2 (de) | Biologische abbaubare multiblokhydrogene und ihre verwendung wie trägerstoffe fur kontrollierte freisetzung pharmakologisch activen werstoffe und gewebekontaktmaterialen | |
| DE69628783T2 (de) | Hydrogelbildende, selbst-solvatisierende, absorbierbare Polyestercopolymere sowie Verfahren zu deren Verwendung | |
| DE69421338T2 (de) | Copolymere aus aromatischen Anhydriden und aliphatischen Estern | |
| DE69829204T2 (de) | Biologisch abbaubare triblock-poly(lactide-co-glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung | |
| DE69736186T2 (de) | Verfahren und zusammensetzungen zur verminderung oder vermeidung der postoperativen adhäsionsbildung | |
| DE69613481T2 (de) | Hydrogele auf basis von dreiblockcopolymerisate, ihre herstellung und ihre verwendung | |
| EP1907023B1 (de) | Resorbierbare polyetherester zur herstellung von medizinischen implantaten | |
| DE60123772T2 (de) | Mischungen von triblockcopolymeren von polyester-polyethylenglycol | |
| DE69318407T2 (de) | Hyaluronsaeure und deren derivate in sich gegenseitig durchdringenden polymernetzwerken | |
| DE69132138T2 (de) | Polyanhydride aus oligomerisierten ungesättigten aliphatischen säuren | |
| DE69730889T2 (de) | Resorbierbare Copolymere und Mischungen von 6,6-Dialkyl-1,4-dioxepan-2-on und seinem cyclischen Dimeren | |
| EP0270987B1 (de) | Verfahren zur Herstellung katalysatorfreier resorbierbarer Homopolymere und Copolymere. | |
| DE69929278T2 (de) | Hydrogelbildende, selbst-solvatisierende, absorbierbare Polyestercopolymere sowie Verfahren zu deren Verwendung | |
| DE69734905T2 (de) | Absorbierbare Polyoxaamide enthaltende Mischungen | |
| DE69937576T2 (de) | Bioabbaubare niedermolekulare triblock-polyester-polyethylenglykol-copolymere mit umgekehrter thermischer gelierung | |
| DE69818693T2 (de) | Neue polymerzusammensetzungen | |
| DE60316115T3 (de) | Dl-lactid-co-e-caprolacton copolymere | |
| DE69026803T2 (de) | Hydrolyse abbaufähiger hydrophiler Gele und Verfahren zu deren Herstellung | |
| EP1519713B1 (de) | Wirkstofffreisetzungssysteme auf basis von bioabbaubaren oder biokompatiblen polymeren mit formgedaechtniseffekt | |
| JPS63118326A (ja) | アルキレンオキサイドのブロツクを含むポリエステル及び薬剤供給系としてのその使用 | |
| DE10005433B4 (de) | Biomaterialien | |
| EP0938342B1 (de) | Injizierbare polymerzusammensetzung zur herstellung eines in-situ-implantats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |